Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Single gene shot could tame rare enzyme disorder

NCT ID NCT06818838

First seen Jan 23, 2026 · Last updated May 23, 2026 · Updated 13 times

Summary

This study tests a one-time gene therapy injection for adults with Gaucher disease type 1, a rare genetic condition that causes organ enlargement and bone problems. The therapy uses a harmless virus to deliver a working gene to the liver, so the body can produce the missing enzyme. The trial will enroll 12 participants to check safety and whether the treatment improves blood counts and reduces organ size.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GAUCHER DISEASE, TYPE 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Guangzhou First People's Hospital

    RECRUITING

    Guangzhou, Guangdong, 510000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hematology Hospital, Chinese Academy of Medical Sciences

    RECRUITING

    Tianjin, Tianjin Municipality, 300011, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shanxi Bethune Hospital

    RECRUITING

    Taiyuan, Shanxi, 030000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.